Calamos Advisors LLC

SEC CIK: 0001316507
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overview All 13F holders of XENE Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of XENE by Calamos Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−30,374−100.0%	Sold out	Holders
Q1 2026	30,374	$1.77M	<0.1%	+30,374	New	Holders
Q3 2023	0	$0	0.0%	−17,637−100.0%	Sold out	Holders
Q2 2023	17,637	$679.0K	<0.1%	+17,637	New	Holders